Publications

Bontell I, Häggblom A, Bratt G, Albert J, Sönnerborg A.

Trends in Antiretroviral Therapy and Prevalence of HIV Drug Resistance Mutations in Sweden 1997-2011

PLoS One. 2013;8(3):e59337. doi: 10.1371/journal.pone.0059337. Epub 2013 Mar 22.

Abecasis AB, Wensing AM, Paraskevis D, Vercauteren J, Theys K, Van de Vijver DA, Albert J, Asjö B, Balotta C, Beshkov D, Camacho RJ, Clotet B, De Gascun C, Griskevicius A, Grossman Z, Hamouda O, Horban A, Kolupajeva T, Korn K, Kostrikis LG, Kücherer C, Liitsola K, Linka M, Nielsen C, Otelea D, Paredes R, Poljak M, Puchhammer-Stöckl E, Schmit JC, Sönnerborg A, Stanekova D, Stanojevic M, Struck D, Boucher CA, Vandamme AM.

HIV-1 subtype distribution and its demographic determinants in newly diagnosed patients in Europe suggest highly compartmentalized epidemics

Retrovirology. 2013 Jan 14;10(1):7

Murillo W, Lorenzana de Rivera I, Albert J, Guardado ME, Nieto AI, Paz-Bailey G

Prevalence of transmitted HIV-1 drug resistance among female sex workers and men who have sex with men in El Salvador, Central America

J Med Virol. 2012 Oct;84(10):1514-21. doi: 10.1002/jmv.23381

Karlsson A, Björkman P, Bratt G, Ekvall H, Gisslén M, Sönnerborg A, Mild M, Albert J.

Low Prevalence of Transmitted Drug Resistance in Patients Newly Diagnosed with HIV-1 Infection in Sweden 2003-2010

PLoS One. 2012;7(3):e33484

Hedskog C, Mild M, Albert J

Transmission of the X4 Phenotype of HIV-1: Is There Evidence Against the "Random Transmission" Hypothesis?

J Infect Dis. 2011 Dec 5

Frentz D, van de Vijver DA, Boucher CA, Albert J

Estimates of HIV transmitted drug resistance can be inflated due to natural sequence polymorphisms

J Acquir Immune Defic Syndr. 2011 Dec 15;58(5):e135-7

Balode D, Skar H, Mild M, Kolupajeva T, Ferdats A, Rozentale B, Leitner T, Albert J.

Phylogenetic analysis of Latvian HIV-1 epidemic.

AIDS Res Hum Retroviruses. 2011 Nov 4.

Albert J, Chiodi F

Towards a world free from HIV and AIDS?

J Intern Med. 2011 Sep 14. doi: 10.1111/j.1365-2796.2011.02453.x.

Skar H, Hedskog C, Albert J

HIV-1 evolution in relation to molecular epidemiology and antiretroviral resistance

Ann N Y Acad Sci. 2011;1230:108-18

Skar H, Gutenkunst RN, Wilbe Ramsay K, Alaeus A, Albert J, Leitner T

Daily Sampling of an HIV-1 Patient with Slowly Progressing Disease Displays Persistence of Multiple env Subpopulations Consistent with Neutrality

PLoS One. 2011;6:e21747

Mild M, Hedskog C, Jernberg J, Albert J.

Performance of Ultra-Deep Pyrosequencing in Analysis of HIV-1 pol Gene Variation

PLoS One. 2011;6(7):e22741. Epub 2011 Jul 25

Thomas Leitner, Michael L. Metzker, Derrick Zwickl, Jeremy M. Brown, Anna Maria Geretti, Annemie Vandamme, Jan Albert, David M. Hillis

Guidelines for HIV in court cases

Nature. 2011 May 19;473(7347):284.

Josefsson L, King MS, Makitalo B, Brännström J, Shao W, Maldarelli F, Kearney MF, Hu WS, Chen J, Gaines H, Mellors JW, Albert J, Coffin JM, Palmer SE

Majority of CD4+ T cells from peripheral blood of HIV-1-infected individuals contain only one HIV DNA molecule

Proc Natl Acad Sci U S A. 2011 Jun 20.

Borggren M, Repits J, Sterjovski J, Uchtenhagen H, Churchill MJ, Karlsson A, Albert J, Achour A, Gorry PR, Fenyö EM, Jansson M.

Increased Sensitivity to Broadly Neutralizing Antibodies of End-Stage Disease R5 HIV-1 Correlates with Evolution in Env Glycosylation and Charge

PLoS One. 2011;6(6):e20135. Epub 2011 Jun 16.

Parham L, de Rivera IL, Murillo W, Naver L, Largaespada N, Albert J, Karlsson AC

High Prevalence of Drug Resistance in HIV Type 1-Infected Children Born in Honduras and Belize 2001 to 2004.

AIDS Res Hum Retroviruses. 2011 May 6

Naver L, Albert J, Belfrage E, Flamholc L, Gisslen M, Gyllensten K, Josephson F, Karlstrom O, Lindgren S, Pettersson K, Svedhem V, Sonnerborg A, Westling K, Yilmaz A

Prophylaxis and treatment of HIV-1 infection in pregnancy: Swedish Recommendations 2010

Scand J Infect Dis 2011

Abecasis AB, Geretti AM, Albert J, Power L, Weait M, Vandamme AM

Science in court: the myth of HIV fingerprinting

Lancet Infect Dis 2011;11:78-9

Campbell MS, Mullins JI, Hughes JP, Celum C, Wong KG, Raugi DN, Sorensen S, Stoddard JN, Zhao H, Deng W, Kahle E, Panteleeff D, Baeten JM, McCutchan FE, Albert J, Leitner T, Wald A, Corey L, Lingappa JR

Viral linkage in HIV-1 seroconverters and their partners in an HIV-1 prevention clinical trial

PLoS One 2011;6:e16986.

Skar H, Axelsson M, Berggren I, Thalme A, Gyllensten K, Liitsola K, Brummer-Korvenkontio H, Kivela P, Spangberg E, Leitner T, Albert J

Dynamics of two separate but linked HIV-1 CRF01_AE outbreaks among injection drug users in Stockholm, Sweden, and Helsinki, Finland

J Virol 2011;85:510-8

Balode D, Westman M, Kolupajeva T, Rozentale B, Albert J.

Low prevalence of transmitted drug resistance among newly diagnosed HIV-1 patients in Latvia

J Med Virol. 2010 Dec;82(12):2013-8

Hedskog C, Mild M, Jernberg J, Sherwood E, Bratt G, Leitner T, Lundeberg J, Andersson B, Albert J

Dynamics of HIV-1 Quasispecies during Antiviral Treatment Dissected Using Ultra-Deep Pyrosequencing

PLoS One 2010;5:e11345

Skar H, Borrego P, Wallstrom TC, Mild M, Marcelino JM, Barroso H, Taveira N, Leitner T, Albert J

HIV-2 genetic evolution in patients with advanced disease is faster than in matched HIV-1 patients

J Virol 2010;84:7412-5.

Murillo W, Paz-Bailey G, Morales S, Monterroso E, Paredes M, Dobbs T, Parekh BS, Albert J, Rivera IL

Transmitted drug resistance and type of infection in newly diagnosed HIV-1 individuals in Honduras

J Clin Virol 2010

Nowroozalizadeh S, Månsson F, da Silva Z, Repits J, Dabo B, Pereira C, Biague A, Albert J, Nielsen J, Aaby P, Fenyö EM, Norrgren H, Holmgren B, Jansson M.

Microbial translocation correlates with the severity of both HIV-1 and HIV-2 infections.

J Infect Dis. 2010 Apr 15;201(8):1150-4.

Wainberg MA, Albert J

Can the further clinical development of bevirimat be justified?

AIDS 2010;24:773-4

Mild M, Simon M, Albert J, Mirazimi A

Towards an understanding of the migration of Crimean-Congo hemorrhagic fever virus

Murillo W, de Rivera IL, Parham L, Jovel E, Palou E, Karlsson AC, Albert J

Prevalence of drug resistance and importance of viral load measurements in Honduran HIV-infected patients failing antiretroviral treatment

HIV Med 2010;11:95-103

Albert J

Kan HIV positiva ha sex utan att smitta?

Smittskydd 2009:28-31

Linde A, Brytting M, Struwe J, Albert J

Darwin's principles direct the development of A/H1N1. Influenza virus evolution enormously complex--the new influenza is not and exception

Lakartidningen 2009;106:1552-5

Josephson F, Albert J, Flamholc L, Gisslen M, Karlstrom O, Moberg L, Naver L, Svedhem V, Svennerholm B, Sonnerborg A

Treatment of HIV infection: Swedish recommendations 2009

Scand J Infect Dis 2009;41:788-807

Vercauteren J, Wensing AM, van de Vijver DA, Albert J, Balotta C, Hamouda O, Kucherer C, Struck D, Schmit JC, Asjo B, Bruckova M, Camacho RJ, Clotet B, Coughlan S, Grossman Z, Horban A, Korn K, Kostrikis L, Nielsen C, Paraskevis D, Poljak M, Puchhammer-Stockl E, Riva C, Ruiz L, Salminen M, Schuurman R, Sonnerborg A, Stanekova D, Stanojevic M, Vandamme AM, Boucher CA.

Transmission of drug-resistant HIV-1 is stabilizing in Europe

J Infect Dis 2009;200:1503-8

Paraskevis D, Pybus O, Magiorkinis G, Hatzakis A, Wensing AM, van de Vijver DA, Albert J, Angarano G, Asjo B, Balotta C, Boeri E, Camacho R, Chaix ML, Coughlan S, Costagliola D, De Luca A, de Mendoza C, Derdelinckx I, Grossman Z, Hamouda O, Hoepelman IM, Horban A, Korn K, Kuecherer C, Leitner T, Loveday C, Macrae E, Maljkovic I, Meyer L, Nielsen C, Op de Coul EL, Ormaasen V, Perrin L, Puchhammer-Stockl E, Ruiz L, Salminen M, Schmit JC, Schuurman R, Soriano V, Stanczak J, Stanojevic M, Struck D, Van Laethem K, Violin M, Yerly S, Zazzi M, Boucher CA, Vandamme AM, Programme S

Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach

Retrovirology 2009;6:49-60

Nowroozalizadeh S, Mansson F, da Silva Z, Repits J, Dabo B, Pereira C, Biague A, Albert J, Nielsen J, Aaby P, Fenyo EM, Norrgren H, Holmgren B, Jansson M

Studies on toll-like receptor stimuli responsiveness in HIV-1 and HIV-2 infections

Cytokine 2009;46:325-31